Growth disorders/growth hormone
We seek technologies and compounds
- With long-acting potential
- Suitable for oral administration
- Suitable for transdermal administration
Our position
We created the world’s first liquid, pre-mixed human growth hormone delivered in a dedicated pen system, Norditropin® SimpleXx®.
Novo Nordisk has been a major player in the field of growth hormone therapy for many decades, and we have world-class expertise in the physiology and pathophysiology of growth and regeneration.
We hold a leading position in the global growth hormone market, aiming for a leadership position – and we explore new indications for human Growth Hormone.
Contact Biopharmaceuticals Sourcing
Novo Nordisk Biotech Fund
